1. Farnesoid X Receptor activation in brain alters brown adipose tissue function via the sympathetic system
- Author
-
Kadiombo Bantubungi, Bart Staels, Emmanuelle Vallez, Emilie Caron, Sophie Lestavel, Benjamin Deckmyn, sarah ducatsel, Julie Charton, Emilie Dorchies, Dorothée Domenger, Benoit Deprez, Anne Tailleux, Jean-Sébastien Annicotte, emilie nicolas, and christophe magnan
- Subjects
Agonist ,medicine.medical_specialty ,Tyrosine hydroxylase ,medicine.drug_class ,Chemistry ,Central nervous system ,Lipid metabolism ,Energy homeostasis ,Endocrinology ,medicine.anatomical_structure ,Internal medicine ,Brown adipose tissue ,medicine ,Farnesoid X receptor ,Receptor - Abstract
Background and Prupose: The nuclear bile acid (BA) receptor farnesoid X receptor (FXR) is a major regulator of metabolic/energy homeostasis in peripheral organs. Indeed, enterohepatic-expressed FXR controls metabolic processes (BA, glucose and lipid metabolism, fat mass, body weight). The central nervous system (CNS) regulates energy homeostasis in close interaction with peripheral organs. While FXR has been reported to be expressed in the brain, its function has not been studied so far. Experimental Approach: We studied the role of FXR in brain control of energy homeostasis by treating wild-type and FXR-deficient mice by intracerebroventricular (ICV) injection with the reference FXR agonist GW4064. Key Results: Here we show that pharmacological activation of brain FXR modifies energy homeostasis by affecting brown adipose tissue (BAT) function. Brain FXR activation decreases the rate-limiting enzyme in catecholamine synthesis, tyrosine hydroxylase (TH), and consequently the sympathetic tone. FXR activation acts by inhibiting hypothalamic PKA-CREB induction of TH expression. Conclusions and Implication: These findings identify a function of brain FXR in the control of energy homeostasis and shed new light on the complex control of energy homeostasis by BA through FXR.
- Published
- 2021
- Full Text
- View/download PDF